Embryo implantation is blocked by intraperitoneal injection with anti-LIF antibody in mice

Journal of Reproduction and Development

Volumn 57, Issue 6, 2011, Pages 700-707

  Terakawa, Jumpei ^a,b   Wakitani, Shoichi ^b   Sugiyama, Makoto ^a,b   Inoue, Naoko ^a   Ohmori, Yasushige ^a   Kiso, Yasuo ^b   Hosaka, Yoshinao Z ^b   Hondo, Eiichi ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Anti LIF antibody; Embryo implantation; Intraperitoneal injection; Leukemia inhibitory factor; Mice

Indexed keywords

HYDROLYASE; IRG1 PROTEIN, MOUSE; LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, MOUSE; NEUTRALIZING ANTIBODY; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLASTOCYST; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MOUSE; NIDATION; UTERUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; BLASTOCYST; EMBRYO IMPLANTATION; FEMALE; HYDRO-LYASES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; UTERUS;

MAMMALIA; MUS; ORYCTOLAGUS CUNICULUS;

EID: 84855973073     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.11-048H     Document Type: Article

References (54)

1. Dey S, Lim H, Das S, Reese J, Paria B, Daikoku T, Wang H. Molecular cues to implantation. Endocr Rev, 2004; 25: 341-373.
2. Wang H, Dey S. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet, 2006; 7: 185-199.
3. Paria B, Huet-Hudson Y, Dey S. Blastocyst's state of activity determines the "window"of implantation in the receptive mouse uterus. Proc Natl Acad Sci USA, 1993; 90: 10159-10162.
4. Bhatt H, Brunet LJ, Stewart CL. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci USA, 1991; 88: 11408-11412.
5. Shen M, Leder P. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci USA, 1992; 89: 8240-8244.
6. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 1992; 359: 76-79.
7. Chen J, Cheng J, Shatzer T, Sewell L, Hernandez L, Stewart C. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology, 2000; 141: 4365-4372.
8. Cheng JG, Rodriguez CI, Stewart CL. Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of implantation". Rev Endocr Metab Disord, 2002; 3: 119-126.
9. Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction, 2005; 130: 131-145.
10. Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA, 1996; 93: 3115-3120.
11. Sengupta J, Lalitkumar PG, Najwa AR, Ghosh D. Monoclonal anti-leukemia inhibitory factor antibody inhibits blastocyst implantation in the rhesus monkey. Contraception, 2006; 74: 419-425.
12. Anegon I, Cuturi M, Godard A, Moreau M, Terqui M, Martinat-Botté F, Soulillou J. Presence of leukaemia inhibitory factor and interleukin 6 in porcine uterine secretions prior to conceptus attachment. Cytokine, 1994; 6: 493-499.
13. Vogiagis D, Salamonsen LA, Sandeman RM, Squires TJ, Butt AR, Fry RC. Effect of immunisation against leukaemia inhibitory factor on the establishment of pregnancy in sheep. Reprod Nutr Dev, 1997; 37: 459-468.
14. Yang ZM, Le SP, Chen DB, Harper MJ. Temporal and spatial expression of leukemia inhibitory factor in rabbit uterus during early pregnancy. Mol Reprod Dev, 1994; 38: 148-152.
15. Laird S, Tuckerman E, Dalton C, Dunphy B, Li T, Zhang X. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod, 1997; 12: 569-574.
16. Steck T, Giess R, Suetterlin MW, Bolland M, Wiest S, Poehls UG, Dietl J. Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur J Obstet Gynecol Reprod Biol, 2004; 112: 69-73.
17. Králícková M, Ulcová-Gallová Z, Síma R, Vanecek T, Síma P, Krizan J, Suchá R, Uher P, Hes O, Novotný Z, Rokyta Z, Vetvicka V. Association of the leukemia inhibitory factor gene mutation and the antiphospholipid antibodies in the peripheral blood of infertile women. Folia Microbiol (Praha), 2007; 52: 543-548.
18. Xiao Y, Sun X, Yang X, Zhang J, Xue Q, Cai B, Zhou Y. Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window. Fertil Steril, 2010; 94: 85-89.
19. Mikolajczyk M, Wirstlein P, Skrzypczak J. Leukaemia inhibitory factor and interleukin 11 levels in uterine flushings of infertile patients with endometriosis. Hum Reprod, 2006; 21: 3054-3058.
20. Dimitriadis E, Sharkey AM, Tan YL, Salamonsen LA, Sherwin JR. Immunolocalisation of phosphorylated STAT3, interleukin 11 and leukaemia inhibitory factor in endometrium of women with unexplained infertility during the implantation window. Reprod Biol Endocrinol, 2007; 5: 44.
21. Yang ZM, Le SP, Chen DB, Cota J, Siero V, Yasukawa K, Harper MJ. Leukemia inhibitory factor, LIF receptor, and gp130 in the mouse uterus during early pregnancy. Mol Reprod Dev, 1995; 42: 407-414.
22. Song H, Lim H, Das SK, Paria BC, Dey SK. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol, 2000; 14: 1147-1161.
23. Cheng J, Chen J, Hernandez L, Alvord W, Stewart C. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci USA, 2001; 98: 8680-8685.
24. Sherwin JR, Freeman TC, Stephens RJ, Kimber S, Smith AG, Chambers I, Smith SK, Sharkey AM. Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. Mol Endocrinol, 2004; 18: 2185-2195.
25. Rodriguez CI, Cheng JG, Liu L, Stewart CL. Cochlin, a secreted von Willebrand factor type a domain-containing factor, is regulated by leukemia inhibitory factor in the uterus at the time of embryo implantation. Endocrinology, 2004; 145: 1410-1418.
26. Marwood M, Visser K, Salamonsen LA, Dimitriadis E. Interleukin-11 and leukemia inhibitory factor regulate the adhesion of endometrial epithelial cells: implications in fertility regulation. Endocrinology, 2009; 150: 2915-2923.
27. Wakitani S, Hondo E, Shimokawa T, Kusakabe K, Okada T, Nakamuta N, Stewart C, Kiso Y. Effects of leukemia inhibitory factor on lectin-binding patterns in the uterine stromal vessels of mice. Immunobiology, 2008; 213: 143-150.
28. Terakawa J, Hondo E, Sugiyama M, Wakitani S, Stewart C, Kiso Y. Agrin pathway is controlled by leukemia inhibitory factor (LIF) in murine implantation. J Reprod Dev, 2009; 55: 293-298.
29. Cai LQ, Cao YJ, Duan EK. Effects of leukaemia inhibitory factor on embryo implantation in the mouse. Cytokine, 2000; 12: 1676-1682.
30. Mitchell MH, Swanson RJ, Oehninger S. In vivo effect of leukemia inhibitory factor (LIF) and an anti-LIF polyclonal antibody on murine embryo and fetal development following exposure at the time of transcervical blastocyst transfer. Biol Reprod, 2002; 67: 460-464.
31. Mohamet L, Heath JK, Kimber SJ. Determining the LIF-sensitive period for implantation using a LIF-receptor antagonist. Reproduction, 2009; 138: 827-836.
32. Nakamura H, Kimura T, Koyama S, Ogita K, Tsutsui T, Shimoya K, Taniguchi T, Koyama M, Kaneda Y, Murata Y. Mouse model of human infertility: transient and local inhibition of endometrial STAT-3 activation results in implantation failure. FEBS Lett, 2006; 580: 2717-2722.
33. Catalano RD, Johnson MH, Campbell EA, Charnock-Jones DS, Smith SK, Sharkey AM. Inhibition of Stat3 activation in the endometrium prevents implantation: a nonsteroidal approach to contraception. Proc Natl Acad Sci USA, 2005; 102: 8585-8590.
34. Parr E, Parr M. Uptake of immunoglobulins and other proteins from serum into epithelial cells of the mouse uterus and oviduct. J Reprod Immunol, 1986; 9: 339-354.
35. Robinson R, Grey L, Staunton D, Vankelecom H, Vernallis A, Moreau J, Stuart D, Heath J, Jones E. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell, 1994; 77: 1101-1116.
36. Hinds M, Maurer T, Zhang J, Nicola N, Norton R. Solution structure of leukemia inhibitory factor. J Biol Chem, 1998; 273: 13738-13745.
37. Bigsby RM, Cooke PS, Cunha GR. A simple efficient method for separating murine uterine epithelial and mesenchymal cells. Am J Physiol, 1986; 251: E630-E636.
38. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem, 1984; 259: 10978-10982.
39. Abe E, Tanaka H, Ishimi Y, Miyaura C, Hayashi T, Nagasawa H, Tomida M, Yamaguchi Y, Hozumi M, Suda T. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA, 1986; 83: 5958-5962.
40. Auernhammer CJ, Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev, 2000; 21: 313-345.
41. White C, Zhang J, Salamonsen L, Baca M, Fairlie W, Metcalf D, Nicola N, Robb L, Dimitriadis E. Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy. Proc Natl Acad Sci USA, 2007; 104: 19357-19362.
42. Wahl RL, Barrett J, Geatti O, Liebert M, Wilson BS, Fisher S, Wagner JG. The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage. Cancer Immunol Immunother, 1988; 26: 187-201.
43. Barrett JS, Wahl RL, Wagner JG, Brown R, Fisher SJ. Investigations into the route of uptake and pharmacokinetics of intraperitoneally-administered monoclonal antibodies: I. Transdiaphragmatic blockade of the terminal lymphatics in the rat. Cancer Immunol Immunother, 1990; 31: 365-372.
44. Edwards C, Milligan SR. Uterine blood flow during the development and regression of the decidual cell reaction in ovariectomized, steroid-treated mice. J Reprod Fertil, 1987; 81: 525-532.
45. Nichols J, Davidson D, Taga T, Yoshida K, Chambers I, Smith A. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev, 1996; 57: 123-131.
46. Lavranos TC, Rathjen PD, Seamark RF. Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos. J Reprod Fertil, 1995; 105: 331-338.
47. Tsai HD, Chang CC, Hsieh YY, Lo HY, Hsu LW, Chang SC. Recombinant human leukemia inhibitory factor enhances the development of preimplantation mouse embryo in vitro. Fertil Steril, 1999; 71: 722-725.
48. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development, 1995; 121: 1283-1299.
49. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature, 2007; 450: 721-724.
50. Fouladi-Nashta AA, Jones CJ, Nijjar N, Mohamet L, Smith A, Chambers I, Kimber SJ. Characterization of the uterine phenotype during the peri-implantation period for LIF-null, MF1 strain mice. Dev Biol, 2005; 281: 1-21.
51. Rose TM, Weiford DM, Gunderson NL, Bruce AG. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine, 1994; 6: 48-54.
52. Conover JC, Ip NY, Poueymirou WT, Bates B, Goldfarb MP, DeChiara TM, Yancopoulos GD. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development, 1993; 119: 559-565.
53. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem, 1995; 270: 10915-10922.
54. Cheon YP, Xu X, Bagchi MK, Bagchi IC. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology, 2003; 144: 5623-5630.